Cargando…
Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1
Metastatic chondrosarcoma of mesenchymal origin is the second most common bone malignancy and does not respond either to chemotherapy or radiation; therefore, the search for new therapies is relevant and urgent. We described recently that tumor growth inhibiting cytostatic proline-rich polypeptide 1...
Autores principales: | GALOIAN, KARINA, QURESHI, AMIR, D’IPPOLITO, GIANLUCA, SCHILLER, PAUL C., MOLINARI, MARCO, JOHNSTONE, ANDREA L., BROTHERS, SHAUN P., PAZ, ANA C., TEMPLE, H.T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501658/ https://www.ncbi.nlm.nih.gov/pubmed/26094604 http://dx.doi.org/10.3892/ijo.2015.3054 |
Ejemplares similares
-
Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide-1
por: Granger, Caroline J., et al.
Publicado: (2020) -
Toll like receptors TLR1/2, TLR6 and MUC5B as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma
por: Galoian, Karina, et al.
Publicado: (2017) -
Genome-wide mRNA and miRNA expression data analysis to screen for markers involved in sarcomagenesis in human chondrosarcoma cell lines
por: Issac, Biju, et al.
Publicado: (2014) -
Morpho-functional study of the hypothalamic proline-rich polypeptide apoptotic activity against mouse Ehrlich ascites carcinoma
por: Abrahamyan, S., et al.
Publicado: (2020) -
Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells
por: Li, Luyuan, et al.
Publicado: (2015)